Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma.

Zhaonan LiQuanjing ChenWenguang ZhangGuangyan SiJing LiDe-Chao Jiao Xinwei Han

Published in: Canadian journal of gastroenterology & hepatology (2021)

aTACE combined with apatinib is a safe and promising treatment approach for patients with advanced HCC. Additionally, tumor burden (≤50%) and the patients without PVTT are associated with better PFS and OS.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
drinking water
combination therapy
risk assessment
risk factors
patient reported outcomes
replacement therapy
radiofrequency ablation